Balchem logo

Balchem

Stock
Stock
Ticker: BCPC
BCPC

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Balchem has so far distributed $0.96 in 2026. The next dividend will be paid on 20.01.2027


$0.234

CHART BY

Frequently asked questions

The market capitalization of Balchem is $5.59B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Balchem is 34.52. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Balchem's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $5.083. EPS indicates the company's profitability on a per-share basis.
Currently, 4 analysts cover Balchem's stock, with a consensus target price of $209.25. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Balchem reported a revenue of $1.09B.
Balchem's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $278.23M. EBITDA measures the company's overall financial performance.
Balchem has a free cash flow of $171.36M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Balchem employs approximately 1,352 people. It operates in the Materials sector, specifically within the Food: Specialty/Candy industry.
The free float of Balchem is 31.70M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$5.59B
EPS (TTM) 
$5.083
Free Float 
31.70M
P/E ratio (TTM) 
34.52
Revenue (TTM) 
$1.09B
EBITDA (TTM) 
$278.23M
Free Cashflow (TTM) 
$171.36M

Pricing

1D span
$168.81$173.01
52W span
$139.24$183.63

Analyst Ratings

The price target is $209.25 and the stock is covered by 4 analysts.

Buy

3

Hold

1

Sell

0

Information

Balchem Corp. markets specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health and Specialty Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment consists of nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The company was founded in 1967 and is headquartered in Montvale, NJ.

Employees
1,352
Industries
Food: Specialty/Candy
Sector
Materials

Identifier

Primary Ticker
BCPC

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation